Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future

por Tamila V. Martynyuk, Irina E. Chazova
Publicado 2021

Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry

por Zarina S. Valieva, Tamila V. Martynyuk, Sergei N. Nakonechnikov, Irina E. Chazova
Publicado 2021

Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat

por Tamila V. Martynyuk, Anton A. Shmalts, Sergey V. Gorbachevsky, Irina E. Chazova
Publicado 2021

Evaluation of heart rate variability in patients with different forms of pulmonary hypertension

por Nasiba Kh. Qurbonbekova, Anna M. Kasparova, Elena Sh. Kozhemyakina, Alexander V. Sobolev, Tamila V. Martynyuk
Publicado 2021

Aspects of efficacy, safety and adherence to antihypertensive therapy with single pill combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galyavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2021

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3...

por Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Publicado 2020